IS5257A - Substitutive pyrazole which inhibits p38 kinase - Google Patents
Substitutive pyrazole which inhibits p38 kinaseInfo
- Publication number
- IS5257A IS5257A IS5257A IS5257A IS5257A IS 5257 A IS5257 A IS 5257A IS 5257 A IS5257 A IS 5257A IS 5257 A IS5257 A IS 5257A IS 5257 A IS5257 A IS 5257A
- Authority
- IS
- Iceland
- Prior art keywords
- substitutive
- pyrazole
- kinase
- inhibits
- substitutive pyrazole
- Prior art date
Links
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 title 1
- 102000002574 p38 Mitogen-Activated Protein Kinases Human genes 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Transplantation (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4757097P | 1997-05-22 | 1997-05-22 | |
| PCT/US1998/010436 WO1998052940A1 (en) | 1997-05-22 | 1998-05-22 | SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS5257A true IS5257A (en) | 1999-11-19 |
Family
ID=21949743
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS5257A IS5257A (en) | 1997-05-22 | 1999-11-19 | Substitutive pyrazole which inhibits p38 kinase |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP1000055A1 (en) |
| JP (1) | JP2002508754A (en) |
| KR (1) | KR20010012854A (en) |
| CN (1) | CN1264377A (en) |
| AP (1) | AP1246A (en) |
| AU (1) | AU754830C (en) |
| BG (1) | BG64313B1 (en) |
| BR (1) | BR9809147A (en) |
| CA (1) | CA2291115A1 (en) |
| EA (1) | EA003925B1 (en) |
| EE (1) | EE9900527A (en) |
| GE (1) | GEP20033053B (en) |
| HU (1) | HUP0001880A3 (en) |
| ID (1) | ID22982A (en) |
| IL (1) | IL132991A (en) |
| IS (1) | IS5257A (en) |
| NO (1) | NO995695L (en) |
| NZ (1) | NZ501112A (en) |
| OA (1) | OA12981A (en) |
| PL (1) | PL337020A1 (en) |
| SK (1) | SK157899A3 (en) |
| TR (1) | TR200000235T2 (en) |
| WO (1) | WO1998052940A1 (en) |
| ZA (1) | ZA984358B (en) |
Families Citing this family (88)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW289752B (en) * | 1994-03-11 | 1996-11-01 | Ciba Geigy Ag | |
| US5559137A (en) * | 1994-05-16 | 1996-09-24 | Smithkline Beecham Corp. | Compounds |
| US6514977B1 (en) | 1997-05-22 | 2003-02-04 | G.D. Searle & Company | Substituted pyrazoles as p38 kinase inhibitors |
| AU7726898A (en) | 1997-05-22 | 1998-12-11 | G.D. Searle & Co. | Pyrazole derivatives as p38 kinase inhibitors |
| US6979686B1 (en) | 2001-12-07 | 2005-12-27 | Pharmacia Corporation | Substituted pyrazoles as p38 kinase inhibitors |
| EP1023066A4 (en) | 1997-06-13 | 2001-05-23 | Smithkline Beecham Corp | Novel pyrazole and pyrazoline substituted compounds |
| US7301021B2 (en) | 1997-07-02 | 2007-11-27 | Smithkline Beecham Corporation | Substituted imidazole compounds |
| US6858617B2 (en) | 1998-05-26 | 2005-02-22 | Smithkline Beecham Corporation | Substituted imidazole compounds |
| US6184226B1 (en) | 1998-08-28 | 2001-02-06 | Scios Inc. | Quinazoline derivatives as inhibitors of P-38 α |
| US6649617B1 (en) | 1998-10-07 | 2003-11-18 | Smithkline Beecham Corporation | Treatment for stroke management |
| ATE258055T1 (en) | 1998-11-04 | 2004-02-15 | Smithkline Beecham Corp | PYRIDINE-4-YL OR PYRIMIDINE-4-YL SUBSTITUTED PYRAZINE |
| CA2355075C (en) | 1998-12-16 | 2009-12-08 | Aventis Pharma Limited | Heteroaryl-cyclic acetals |
| US6191147B1 (en) * | 1998-12-24 | 2001-02-20 | Ppd Discovery, Inc. | Pyrazole compounds and uses thereof |
| WO2000039116A1 (en) * | 1998-12-25 | 2000-07-06 | Teikoku Hormone Mfg. Co., Ltd. | Aminopyrazole derivatives |
| UA72244C2 (en) | 1999-03-26 | 2005-02-15 | Aryl-substituted pyrazols, imidazols, oxazols, thiazols, pyrrols and their use | |
| CN1281604C (en) * | 1999-06-03 | 2006-10-25 | 帝国脏器制药株式会社 | Substituted pyrazole compounds |
| US7122666B2 (en) | 1999-07-21 | 2006-10-17 | Sankyo Company, Limited | Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses |
| JP2003531103A (en) * | 1999-08-12 | 2003-10-21 | バーテックス ファーマシューティカルズ インコーポレイテッド | Inhibitors of c-JUNN-terminal kinase (JNK) and other protein kinases |
| AU7922100A (en) * | 1999-10-25 | 2001-05-08 | Basf Aktiengesellschaft | Agrochemical compositions containing pyrazoles as the active agents and use of said compositions as plant protection agents with a fungicidal action |
| DE19952147A1 (en) | 1999-10-29 | 2001-05-03 | Boehringer Ingelheim Pharma | New cyclopropanes, pharmaceutical compositions containing these compounds and process for their preparation |
| WO2001038314A1 (en) | 1999-11-23 | 2001-05-31 | Smithkline Beecham Corporation | 3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors |
| ES2249309T3 (en) | 1999-11-23 | 2006-04-01 | Smithkline Beecham Corp | COMPOUNDS OF 3,4-DIHIDRO- (1H) QUINAZOLIN-2-ONA AS INHIBITORS OF CSBP / P39 KINASA. |
| ES2230171T3 (en) | 1999-11-23 | 2005-05-01 | Smithkline Beecham Corporation | 3,4-DIHIDRO- (1H) QUINAZOLIN-2-ONA COMPOUNDS AS CSBP / P38 QUINASA INHIBITORS. |
| US7235551B2 (en) | 2000-03-02 | 2007-06-26 | Smithkline Beecham Corporation | 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases |
| NZ524192A (en) | 2000-08-14 | 2005-02-25 | Ortho Mcneil Pharm Inc | Substituted pyrazoles |
| GB0102687D0 (en) | 2001-02-02 | 2001-03-21 | Pharmacia & Upjohn Spa | Oxazolyl-pyrazole derivatives active as kinase inhibitors,process for their preparation and pharmaceutical compositions comprising them |
| WO2002062792A1 (en) * | 2001-02-02 | 2002-08-15 | Takeda Chemical Industries, Ltd. | Jnk inhibitor |
| DE60227794D1 (en) | 2001-04-26 | 2008-09-04 | Eisai R&D Man Co Ltd | NITROGENIC COMPOUND WITH CONDENSED RING AND PYRAZOLYL GROUP AS A SUBSTITUENT AND MEDICAL COMPOSITION THEREOF |
| SK287857B6 (en) | 2001-05-24 | 2012-01-04 | Eli Lilly And Company | Novel pyrrole derivatives as pharmaceutical agents |
| US7057049B2 (en) | 2001-09-25 | 2006-06-06 | Pharmacia Corporation | Process for making substituted pyrazoles |
| RU2277534C2 (en) * | 2001-09-25 | 2006-06-10 | Фармация Корпорейшн | Method for preparing substituted pyrazoles |
| IL161009A0 (en) | 2001-09-25 | 2004-08-31 | Pharmacia Corp | Process for making substituted pyrazoles |
| US20040082551A1 (en) * | 2002-06-05 | 2004-04-29 | Benson Alan G. | Novel pyrazoles and their use as p38 kinase inhibitors |
| GB0215844D0 (en) | 2002-07-09 | 2002-08-14 | Novartis Ag | Organic compounds |
| ES2278170T3 (en) | 2002-07-09 | 2007-08-01 | BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG | PHARMACEUTICAL COMPOSITIONS OF ANTICOLINERGIC AND INHIBITORS OF QUINASE P38 IN THE TREATMENT OF RESPIRATORY DISEASES. |
| GB0217786D0 (en) * | 2002-07-31 | 2002-09-11 | Glaxo Group Ltd | Compounds |
| AU2003265395A1 (en) | 2002-08-14 | 2004-03-03 | Ppd Discovery, Inc. | Prenylation inhibitors and methods of their synthesis and use |
| US6649638B1 (en) | 2002-08-14 | 2003-11-18 | Ppd Discovery, Inc. | Prenylation inhibitors and methods of their synthesis and use |
| WO2004026302A1 (en) * | 2002-09-19 | 2004-04-01 | Eli Lilly And Company | Methods of inhibiting tgf beta with substituted pyrazoles |
| GB0229618D0 (en) * | 2002-12-19 | 2003-01-22 | Cancer Rec Tech Ltd | Pyrazole compounds |
| DE602004028800D1 (en) | 2003-02-07 | 2010-10-07 | Daiichi Sankyo Co Ltd | Pyrazolderivat |
| US20060035893A1 (en) | 2004-08-07 | 2006-02-16 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders |
| EP1778686B9 (en) | 2004-08-12 | 2009-07-08 | Pfizer Limited | Triazolopyridinylsulfanyl derivatives as p38 map kinase inhibitors |
| PE20060777A1 (en) | 2004-12-24 | 2006-10-06 | Boehringer Ingelheim Int | INDOLINONE DERIVATIVES FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES |
| WO2006070927A1 (en) | 2004-12-28 | 2006-07-06 | Aska Pharmaceutical Co., Ltd. | Pyrimidinylisoxazol derivative |
| EP2024353A2 (en) * | 2006-03-16 | 2009-02-18 | Pfizer Products Inc. | Pyrazole compounds |
| JP5244591B2 (en) | 2006-06-28 | 2013-07-24 | あすか製薬株式会社 | Pyridylisoxazole derivatives |
| CN101478989A (en) * | 2006-06-28 | 2009-07-08 | Aska制药株式会社 | Treatment agent for inflammatory bowel disease |
| AU2008215659B2 (en) | 2007-02-16 | 2012-11-01 | Aska Pharmaceutical Co., Ltd. | Pharmaceutical composition comprising microparticle oily suspension |
| EP1992344A1 (en) | 2007-05-18 | 2008-11-19 | Institut Curie | P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation |
| JP2010533147A (en) * | 2007-07-13 | 2010-10-21 | アデックス ファルマ エス．エイ． | Pyrazole derivatives as modulators of metabotropic glutamate receptors |
| CL2008003407A1 (en) | 2007-11-16 | 2010-01-11 | Boehringer Ingelheim Int | Substituted heterobicyclo aryl- and heteroarylcarbonyl derivative compounds; pharmaceutical composition; preparation procedure; and its use in the treatment and / or prevention of metabolic disorders, mediated by the inhibition of the enzyme hsd-1. |
| CL2009000904A1 (en) * | 2008-04-21 | 2010-04-30 | Shionogi & Co | Compounds derived from cyclohexyl sulfonamides having antagonist activity at the npy y5 receptor, pharmaceutical composition and pharmaceutical formulation comprising them. |
| TW200950780A (en) | 2008-05-13 | 2009-12-16 | Boehringer Ingelheim Int | Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use |
| AU2009273197B2 (en) | 2008-07-24 | 2014-01-16 | Nerviano Medical Sciences S.R.L. | 3,4-diarylpyrazoles as protein kinase inhibitors |
| CA2735204C (en) * | 2008-08-25 | 2017-06-20 | Boehringer Ingelheim International Gmbh | Aryl- and heteroarylcarbonyl derivatives of substituted nortropanes, medicaments containing such compounds and their use |
| KR20110070885A (en) * | 2008-10-23 | 2011-06-24 | 론자 리미티드 | Synthesis method of substituted pyrazole |
| BRPI0921097B8 (en) * | 2008-11-21 | 2021-05-25 | Raqualia Pharma Inc | compound or its pharmaceutically acceptable salt, intermediate of the compound, pharmaceutical composition and use of the compound |
| EP2438049B1 (en) | 2009-06-02 | 2014-05-14 | Boehringer Ingelheim International GmbH | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| WO2011011123A1 (en) | 2009-06-11 | 2011-01-27 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure |
| IN2012DN01693A (en) * | 2009-08-26 | 2015-06-05 | Novartis Ag | |
| JO3002B1 (en) | 2009-08-28 | 2016-09-05 | Irm Llc | Protein kinase inhibitors |
| EP2308866A1 (en) * | 2009-10-09 | 2011-04-13 | Bayer CropScience AG | Phenylpyri(mi)dinylpyrazoles and their use as fungicides |
| CN102762551A (en) | 2009-12-21 | 2012-10-31 | 拜尔农作物科学股份公司 | Thienylpyrimidinylpyrazoles and their use for controlling plant pathogens |
| WO2011092088A1 (en) | 2010-01-27 | 2011-08-04 | Nerviano Medical Sciences S.R.L. | Sulfonamido derivatives of 3,4-diarylpyrazoles as protein kinase inhibitors |
| AR081810A1 (en) | 2010-04-07 | 2012-10-24 | Bayer Cropscience Ag | BICYCLE PIRIDINYL PIRAZOLS |
| JP5860042B2 (en) | 2010-06-16 | 2016-02-16 | ヴァイティー ファーマシューティカルズ，インコーポレイテッド | Substituted 5, 6 and 7 membered heterocycles, medicaments containing such compounds and their use |
| JP5938038B2 (en) | 2010-08-03 | 2016-06-22 | ネルヴィアーノ・メディカル・サイエンシズ・ソチエタ・ア・レスポンサビリタ・リミタータ | Derivatives of pyrazolophenyl-benzenesulfonamide compounds and their use as antitumor agents |
| WO2012085721A1 (en) * | 2010-12-20 | 2012-06-28 | Pfizer Inc. | Novel fused pyridine compounds as casein kinase inhibitors |
| WO2012175513A1 (en) | 2011-06-20 | 2012-12-27 | Bayer Intellectual Property Gmbh | Thienylpyri(mi)dinylpyrazole |
| JP2014524438A (en) | 2011-08-17 | 2014-09-22 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Indenopyridine derivatives |
| WO2013050434A1 (en) | 2011-10-06 | 2013-04-11 | Bayer Intellectual Property Gmbh | Heterocyclylpyri(mi)dinylpyrazole |
| UA114490C2 (en) | 2011-10-06 | 2017-06-26 | Байєр Інтеллектуал Проперті Гмбх | Heterocyclylpyri(mi)dinylpyrazole as fungicidals |
| DE102011115525A1 (en) | 2011-10-11 | 2013-04-11 | Boehringer Ingelheim International Gmbh | Two-part bottle packaging device for containing pharmaceutical tablets or capsules, has bottle body and bottle base, where bottle is closed with pressure lock or with pressure lock injected at bottle body or with separate rotary lock |
| CN103917236A (en) | 2011-11-11 | 2014-07-09 | 诺华股份有限公司 | Methods of treating proliferative diseases |
| DK2782557T3 (en) | 2011-11-23 | 2018-12-10 | Array Biopharma Inc | PHARMACEUTICAL FORMULATIONS |
| KR102283996B1 (en) | 2013-03-15 | 2021-07-29 | 더 스크립스 리서치 인스티튜트 | Compounds and methods for inducing chondrogenesis |
| US9573904B2 (en) * | 2013-12-12 | 2017-02-21 | Sumitomo Chemical Company, Limited | Aromatic compound and use thereof |
| CN104829536B (en) * | 2015-05-04 | 2017-12-29 | 陕西科技大学 | A kind of Phenylpyrazole carboxylic acid compound and its synthetic method for having antitumor activity |
| EP3303284B1 (en) * | 2015-05-27 | 2020-04-08 | Kyorin Pharmaceutical Co., Ltd. | Urea derivative or pharmacologically acceptable salt thereof |
| CN112457255B (en) * | 2017-11-08 | 2022-08-19 | 北京嘉林药业股份有限公司 | Compounds and their use for treating cancer |
| EP3886854A4 (en) | 2018-11-30 | 2022-07-06 | Nuvation Bio Inc. | PYRROLE AND PYRAZOLE COMPOUNDS AND METHODS OF USE THEREOF |
| WO2020124397A1 (en) | 2018-12-19 | 2020-06-25 | Inventisbio Shanghai Ltd. | C-terminal src kinase inhibitors |
| US12479816B2 (en) | 2019-02-08 | 2025-11-25 | University of Pittsburgh—of the Commonwealth System of Higher Education | 20-HETE formation inhibitors |
| US11091447B2 (en) | 2020-01-03 | 2021-08-17 | Berg Llc | UBE2K modulators and methods for their use |
| EP3978487A1 (en) * | 2020-09-30 | 2022-04-06 | Origo Biopharma, S.L. | 2-(3-pyridin-2-yl-4-quinolin-4-yl-pyrazol-1-yl)-acetamide derivatives as inhibitors of transforming growth factor-beta receptor i/alk5 |
| WO2022146698A1 (en) * | 2020-12-29 | 2022-07-07 | Revolution Medicines, Inc. | Sos1 inhibitors and uses thereof |
| WO2025231152A1 (en) * | 2024-04-30 | 2025-11-06 | The Cleveland Clinic Foundation | Compounds and methods for restoring beta-adrenergic receptor function |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2753659B2 (en) * | 1990-09-03 | 1998-05-20 | 株式会社大塚製薬工場 | Pyrazole derivatives |
| US5593992A (en) * | 1993-07-16 | 1997-01-14 | Smithkline Beecham Corporation | Compounds |
| US5559137A (en) * | 1994-05-16 | 1996-09-24 | Smithkline Beecham Corp. | Compounds |
| US5486534A (en) * | 1994-07-21 | 1996-01-23 | G. D. Searle & Co. | 3,4-substituted pyrazoles for the treatment of inflammation |
| JP3734180B2 (en) * | 1994-12-28 | 2006-01-11 | エーザイ株式会社 | New pyrazole derivatives |
-
1998
- 1998-05-22 HU HU0001880A patent/HUP0001880A3/en unknown
- 1998-05-22 CN CN98807369A patent/CN1264377A/en active Pending
- 1998-05-22 EP EP98923642A patent/EP1000055A1/en not_active Withdrawn
- 1998-05-22 ID IDW991425A patent/ID22982A/en unknown
- 1998-05-22 PL PL98337020A patent/PL337020A1/en unknown
- 1998-05-22 JP JP55065098A patent/JP2002508754A/en not_active Withdrawn
- 1998-05-22 AU AU75883/98A patent/AU754830C/en not_active Ceased
- 1998-05-22 EE EEP199900527A patent/EE9900527A/en unknown
- 1998-05-22 GE GEAP19985095A patent/GEP20033053B/en unknown
- 1998-05-22 TR TR2000/00235T patent/TR200000235T2/en unknown
- 1998-05-22 EA EA199900953A patent/EA003925B1/en not_active IP Right Cessation
- 1998-05-22 NZ NZ501112A patent/NZ501112A/en unknown
- 1998-05-22 KR KR19997010820A patent/KR20010012854A/en not_active Ceased
- 1998-05-22 SK SK1578-99A patent/SK157899A3/en unknown
- 1998-05-22 WO PCT/US1998/010436 patent/WO1998052940A1/en not_active Ceased
- 1998-05-22 ZA ZA984358A patent/ZA984358B/en unknown
- 1998-05-22 AP APAP/P/1999/001715A patent/AP1246A/en active
- 1998-05-22 CA CA002291115A patent/CA2291115A1/en not_active Abandoned
- 1998-05-22 IL IL13299198A patent/IL132991A/en not_active IP Right Cessation
- 1998-05-22 BR BR9809147-6A patent/BR9809147A/en not_active Application Discontinuation
-
1999
- 1999-11-19 NO NO995695A patent/NO995695L/en not_active Application Discontinuation
- 1999-11-19 IS IS5257A patent/IS5257A/en unknown
- 1999-11-22 OA OA9900252A patent/OA12981A/en unknown
- 1999-12-08 BG BG103964A patent/BG64313B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL337020A1 (en) | 2000-07-31 |
| EA003925B1 (en) | 2003-10-30 |
| SK157899A3 (en) | 2000-08-14 |
| HUP0001880A3 (en) | 2002-03-28 |
| AP9901715A0 (en) | 1999-12-31 |
| AU754830C (en) | 2004-02-12 |
| BG64313B1 (en) | 2004-09-30 |
| CN1264377A (en) | 2000-08-23 |
| AU7588398A (en) | 1998-12-11 |
| BR9809147A (en) | 2000-08-01 |
| HUP0001880A2 (en) | 2001-03-28 |
| GEP20033053B (en) | 2003-08-25 |
| KR20010012854A (en) | 2001-02-26 |
| EP1000055A1 (en) | 2000-05-17 |
| IL132991A (en) | 2005-11-20 |
| ID22982A (en) | 1999-12-23 |
| ZA984358B (en) | 1999-05-24 |
| CA2291115A1 (en) | 1998-11-26 |
| JP2002508754A (en) | 2002-03-19 |
| EE9900527A (en) | 2000-06-15 |
| EA199900953A1 (en) | 2000-10-30 |
| WO1998052940A1 (en) | 1998-11-26 |
| NO995695D0 (en) | 1999-11-19 |
| AP1246A (en) | 2004-02-07 |
| NZ501112A (en) | 2002-10-25 |
| AU754830B2 (en) | 2002-11-28 |
| OA12981A (en) | 2006-10-13 |
| BG103964A (en) | 2000-08-31 |
| IL132991A0 (en) | 2001-03-19 |
| NO995695L (en) | 2000-01-21 |
| TR200000235T2 (en) | 2000-05-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS5257A (en) | Substitutive pyrazole which inhibits p38 kinase | |
| IS5938A (en) | Substituted pyrazole which inhibits P38 kinase | |
| IS6298A (en) | Teridinone which inhibits kinase | |
| NO20001907D0 (en) | pyrazole | |
| NO20002121D0 (en) | Benzothiazol-protein-tyrosine kinase inhibitors | |
| IS5069A (en) | Nitrogen substituents with nitrogen inhibiting p38 protein kinase | |
| NO995635D0 (en) | 3 (5) heteroaryl-substituted pyrazoles as p38 kinase inhibitors | |
| IS4936A (en) | Bicyclic heteroaromatic compounds that inhibit protein tyrosine kinase | |
| IS4939A (en) | Bicyclic heteroaromatic compounds that inhibit protein tyrosine kinase | |
| IS6326A (en) | Tyrosine kinase inhibits | |
| DE69830089D1 (en) | Multilevel memory | |
| ID20287A (en) | TRIAZIN RESORSINIL | |
| NO20003154D0 (en) | Insert the plug | |
| DE69918223D1 (en) | Component feeder | |
| DK1089964T3 (en) | hydrazine | |
| ITMI992109A0 (en) | GRAFT | |
| EP1135135A4 (en) | Chk1 kinase inhibitors | |
| DK0967869T3 (en) | fungicidal | |
| DE69719304D1 (en) | component feeders | |
| EE04318B1 (en) | Enhanced LHRH antagonists | |
| IT1302265B1 (en) | SYNERGIC STABILIZING MIXTURES | |
| DK1133471T3 (en) | hydrazine | |
| GB0023243D0 (en) | Protein kinase regulation | |
| IT1302498B1 (en) | MODULAR TRUNK | |
| FI980244A0 (en) | Maetare Foer att maeta optiš fibrets belaeggning |